These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2184878)

  • 1. Intravesical therapy in the management of superficial transitional cell carcinoma of the bladder: the experience of the EORTC GU Group.
    Newling D
    Br J Cancer; 1990 Apr; 61(4):497-9. PubMed ID: 2184878
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravesical adjuvant treatment in superficial bladder cancer. A review of the question after 15 years of experience with the EORTC GU group.
    Bouffioux C
    Scand J Urol Nephrol Suppl; 1991; 138():167-77. PubMed ID: 1838428
    [No Abstract]   [Full Text] [Related]  

  • 3. [Conservative treatment of superficial transitional cell carcinoma of the bladder].
    Gruenwald I; Stein A; Lurie A
    Harefuah; 1995 Jan; 128(2):104-11. PubMed ID: 7721171
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravesical therapy: does it affect the natural history of superficial bladder cancer?
    Lamm DL; Griffith JG
    Semin Urol; 1992 Feb; 10(1):39-44. PubMed ID: 1565903
    [No Abstract]   [Full Text] [Related]  

  • 5. Superficial transitional (Ta/T1/CIS) cell carcinoma of the bladder.
    Konety BR; Williams RD
    BJU Int; 2004 Jul; 94(1):18-21. PubMed ID: 15217424
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravesical therapy for bladder cancer.
    Kamat AM; Lamm DL
    Urology; 2000 Feb; 55(2):161-8. PubMed ID: 10688071
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravesical interferon alfa in the treatment of superficial bladder cancer.
    Williams RD
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):10-3. PubMed ID: 3057641
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of superficial transitional cell carcinoma of the bladder.
    Fleischmann J; Goldberg G
    Semin Urol; 1993 Nov; 11(4):193-204. PubMed ID: 8290825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.
    Debruyne FM; van der Meijden AP; Franssen MP
    Prog Clin Biol Res; 1989; 303():435-46. PubMed ID: 2506556
    [No Abstract]   [Full Text] [Related]  

  • 10. Contemporary management of superficial bladder cancer.
    Pow-Sang JM; Seigne JD
    Cancer Control; 2000; 7(4):335-9. PubMed ID: 10895127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical therapy for superficial bladder cancer.
    Malkowicz SB
    Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery and intravesical chemotherapy in the management of superficial bladder cancer.
    Soloway MS
    Semin Urol; 1983 Feb; 1(1):23-33. PubMed ID: 6433424
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment modalities in superficial bladder cancer.
    Irwin R; Zincke H; Droller MJ; Prout GR; Soloway MS
    Semin Urol; 1989 Feb; 7(1 Suppl 1):1-12. PubMed ID: 2499916
    [No Abstract]   [Full Text] [Related]  

  • 14. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT; Soloway MS
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment and follow-up of superficial bladder cancer].
    Raitanen M
    Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pitfalls in intravesical immunotherapy of superficial carcinoma of the gallbladder with BCG vaccine].
    Pacík D; Vít V; Turjanica M
    Rozhl Chir; 1997 Jan; 76(1):3-5. PubMed ID: 9182342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder: an overview.
    Witjes JA; vd Meijden AP; Debruyne FM
    Urol Int; 1990; 45(3):129-36. PubMed ID: 2190404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When does superficial bladder cancer resist intravesical therapy?
    Vögeli T; Ackermann R
    Semin Urol; 1990 Nov; 8(4):248-53. PubMed ID: 2284531
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravesical therapy for superficial bladder cancer: slow but steady progress.
    Lamm DL
    J Clin Oncol; 2003 Dec; 21(23):4259-60. PubMed ID: 14581444
    [No Abstract]   [Full Text] [Related]  

  • 20. Principles of intravesical chemotherapy and immunotherapy.
    Sarosdy MF
    Urol Clin North Am; 1992 Aug; 19(3):509-19. PubMed ID: 1636235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.